NASDAQ:ARWR

Arrowhead Pharmaceuticals - ARWR Earnings Date, Estimates & Call Transcripts

$35.29

+0.30 (+0.86%)

(As of 02/1/2023 12:00 AM ET)

Add

Compare

Today's Range: $34.27
▼
$35.88
50-Day Range: $28.00
▼
$40.56
52-Week Range: $26.81
▼
$56.25

Volume: 767,956 shs
Average Volume: 1.10 million shs
Market Capitalization: $3.77 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $59.22

Institutional Ownership

Upcoming Earnings Date: Feb. 6Confirmed
Actual EPS (Nov. 28): -$0.81 Missed By -$0.24
Consensus EPS (Nov. 28): -$0.57
Last Year's Q4 EPS (11/22/2021): -$0.61

Earnings Per Share Revenue

ARWR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ARWR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Arrowhead Pharmaceuticals Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2023	5	($0.81)	$1.34	$0.25
Q2 2023	6	($1.09)	$0.16	($0.73)
Q3 2023	6	($1.12)	$0.15	($0.73)
Q4 2023	6	($1.12)	$0.15	($0.77)
FY 2023	23	($4.14)	$1.80		($1.97)

ARWR Earnings Date and Information

Arrowhead Pharmaceuticals last announced its quarterly earnings data on November 28th, 2022. The biotechnology company reported ($0.81) EPS for the quarter, missing the consensus estimate of ($0.57) by $0.24. The business had revenue of $31.58 million for the quarter, compared to the consensus estimate of $107.60 million. Arrowhead Pharmaceuticals has generated ($1.68) earnings per share over the last year (($1.68) diluted earnings per share). Earnings for Arrowhead Pharmaceuticals are expected to decrease in the coming year, from ($1.16) to ($2.47) per share. Arrowhead Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Monday, February 6th, 2023. Arrowhead Pharmaceuticals will be holding an earnings conference call on Monday, February 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Arrowhead Pharmaceuticals Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
2/6/2023 (Confirmed)		$1.14
11/28/2022	Q4 2022	($0.57)	($0.81)	($0.24)	($0.81)	$107.60 million	$31.58 million
8/4/2022	Q3 2022	($0.45)	($0.68)	($0.23)	($0.68)	$52.61 million	$32.41 million
5/10/2022	Q2 2022	$0.39	$0.41	+$0.02	$0.41	$122.15 million	$151.80 million
2/2/2022	Q1 2022	($0.22)	($0.60)	($0.38)	($0.60)	$67.30 million	$27.44 million
11/22/2021	9/30/2021	$0.04	($0.61)	($0.65)	($0.61)	$79.31 million	$38.28 million
8/4/2021	6/30/2021	($0.08)	($0.29)	($0.21)	($0.29)	$50.20 million	$45.89 million

5/3/2021	3/31/2021	($0.09)	($0.26)	($0.17)	($0.26)	$39.42 million	$32.81 million
2/3/2021	12/31/2020	$1.00	($0.20)	($1.20)	($0.20)	$157.48 million	$21.30 million
11/22/2020	9/30/2020	$0.34	($0.48)	($0.82)	($0.48)	$85.13 million	$7.63 million
8/5/2020	6/30/2020	($0.07)	($0.13)	($0.06)	($0.13)	$38.76 million	$27.38 million
5/7/2020	3/31/2020	($0.11)	($0.20)	($0.09)	($0.20)	$21.90 million	$23.53 million
2/5/2020	12/31/2019	$0.04	($0.03)	($0.07)	($0.03)	$36.63 million	$29.46 million
11/25/2019	Q4	$0.14	$0.11	($0.03)	$0.11	$36.97 million	$43.29 million
8/5/2019	Q3 2019	$0.34	$0.21	($0.13)	$0.21	$59.05 million	$42.70 million
5/8/2019	3/31/2019	$0.22	$0.24	+$0.02	$0.24	$45.78 million	$48.15 million
2/7/2019	12/31/2018	$0.76	$0.13	($0.63)	$0.13	$90.88 million	$34.66 million
12/11/2018	Q4 2018	($0.17)	($0.12)	+$0.05	($0.12)	$3.73 million	$11.26 million
8/7/2018	Q3 2018	($0.19)	($0.18)	+$0.01	($0.18)	$0.62 million	$0.73 million
5/8/2018	Q2 2018	($0.19)	($0.18)	+$0.01	($0.18)	$4.04 million	$0.65 million
2/9/2018	Q1 2018	($0.14)	($0.18)	($0.04)	($0.18)	$8.71 million	$3.51 million
12/12/2017	Q4 2017	($0.12)	($0.14)	($0.02)	($0.14)	$7.32 million	$8.71 million
8/3/2017	Q3 2017	($0.13)	($0.07)	+$0.06	($0.07)	$5.29 million	$9.34 million
5/3/2017	Q2 2017	($0.1230)	($0.08)	+$0.0430	($0.08)	$4.19 million	$8.99 million
2/6/2017	Q117	($0.20)	($0.17)	+$0.03	($0.17)	$13.24 million	$4.37 million
12/14/2016	Q4 2016	($0.33)	($0.31)	+$0.02	($0.28)	$0.04 million	$0.03 million
8/9/2016	Q316	($0.37)	($0.32)	+$0.05	($0.32)	$0.05 million	$39.58 million
5/10/2016	Q216	($0.37)	($0.35)	+$0.02	($0.35)	$0.26 million	$0.04 million
2/9/2016	Q1	($0.41)	($0.32)	+$0.09	($0.32)	$0.29 million	$0.04 million
12/14/2015	Q415	($0.39)	($0.42)	($0.03)	($0.42)	$0.14 million	$0.04 million
8/4/2015	Q315	($0.38)	($0.27)	+$0.11	($0.27)	$0.11 million	$0.12 million
5/11/2015	Q214	($0.35)	($0.33)	+$0.02	($0.15)	$110.00 million	$43.75 million
2/9/2015	Q114	($0.32)	($0.41)	($0.09)	($0.41)	$0.24 million	$0.17 million
11/25/2014	Q413	($0.25)	($0.33)	($0.08)	($0.24)	$0.04 million	$0.04 million
8/12/2014	Q313	($0.22)	($0.22)		($0.22)	$0.04 million	$0.04 million
5/6/2014	Q2 2014	($0.18)	($0.31)	($0.13)	($0.31)	$0.05 million	$0.04 million
2/4/2014	Q1 2014	($0.18)	($0.28)	($0.10)	($0.28)	$0.05 million	$0.04 million
12/18/2013	Q4	($0.23)	($0.43)	($0.20)
8/7/2013	Q3 2013	($0.22)	($0.23)	($0.01)	($0.23)	$0.50 million	$0.04 million
5/9/2013	Q2 2013		($0.41)	($0.41)	($0.41)		$0.04 million
2/13/2013	Q1 2013		($0.33)	($0.33)

12/20/2012	Q4 2012		($0.43)	($0.43)
8/13/2012	Q3 2012		($0.71)	($0.71)	($0.71)
5/8/2012	Q2 2012		($0.44)	($0.44)	($0.38)
2/9/2012	Q1 2012		($0.25)	($0.25)	($0.25)
12/20/2011	Q4 2011		($0.39)	($0.39)	($0.39)
8/8/2011	Q3 2011	($0.20)	($0.26)	($0.06)	($0.27)
5/12/2011	Q2 2011	($0.20)	($0.18)	+$0.02	($0.73)
2/10/2011	Q1 2011		($0.20)	($0.20)	($0.20)
12/22/2010	Q4 2010	($0.30)	($0.28)	+$0.02	($0.28)
8/12/2010	Q3 2010	($0.50)	($0.06)	+$0.44	($0.06)
5/13/2010	Q2 2010	($0.40)	($0.33)	+$0.07	($0.33)
2/11/2010	Q1 2010		($0.30)	($0.30)	($0.30)
12/22/2009	Q4 2009		($0.60)	($0.60)	($0.60)
8/10/2009	Q3 2009		($0.60)	($0.60)	($0.60)
5/15/2009	Q2 2009		($1.20)	($1.20)	($1.20)
2/9/2009	Q1 2009		($1.90)	($1.90)	($1.90)
12/15/2008	Q4 2008		($2.14)	($2.14)	($2.14)
8/11/2008	Q3 2008		($1.90)	($1.90)	($1.90)
2/11/2008	Q1 2008		($1.40)	($1.40)	($1.40)

Arrowhead Pharmaceuticals Earnings - Frequently Asked Questions

When is Arrowhead Pharmaceuticals's earnings date?: Arrowhead Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Monday, February 6th, 2023. Learn more on ARWR's earnings history.
Did Arrowhead Pharmaceuticals beat their earnings estimates last quarter?: In the previous quarter, Arrowhead Pharmaceuticals (NASDAQ:ARWR) missed the analysts' consensus estimate of ($0.57) by $0.24 with a reported earnings per share (EPS) of ($0.81). Learn more on analysts' earnings estimate vs. ARWR's actual earnings.

How much revenue does Arrowhead Pharmaceuticals generate each year?: Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded annual revenue of $243.23 million.
How much profit does Arrowhead Pharmaceuticals generate each year?: Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded net income of -$176.06 million. ARWR has generated -$1.68 earnings per share over the last four quarters.
What is Arrowhead Pharmaceuticals's EPS forecast for next year?: Arrowhead Pharmaceuticals's earnings are expected to decrease from ($1.16) per share to ($2.47) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

Regeneron Pharmaceuticals (2/3/2023)
Sanofi (2/3/2023)
AON (2/3/2023)
Cigna (2/3/2023)
Activision Blizzard (2/6/2023)
Fiserv (2/7/2023)
Vertex Pharmaceuticals (2/7/2023)
BP (2/7/2023)
Linde (2/7/2023)
CME Group (2/8/2023)

This page (NASDAQ:ARWR) was last updated on 2/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Arrowhead Pharmaceuticals - ARWR Earnings Date, Estimates & Call Transcripts

ARWR Earnings Estimates and Actuals by Quarter

ARWR Estimated and Actual Revenue by Quarter

Arrowhead Pharmaceuticals Analyst Forecasts

ARWR Earnings Date and Information

Arrowhead Pharmaceuticals Earnings History by Quarter

Arrowhead Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Arrowhead Pharmaceuticals - ARWR Earnings Date, Estimates & Call Transcripts

Earnings Summary

ARWR Earnings Estimates and Actuals by Quarter

ARWR Estimated and Actual Revenue by Quarter

Arrowhead Pharmaceuticals Analyst Forecasts

ARWR Earnings Date and Information

Arrowhead Pharmaceuticals Earnings History by Quarter

Arrowhead Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat